Vanguard Group Inc Precigen, Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PGEN
# of Institutions
142Shares Held
145MCall Options Held
208KPut Options Held
43.7K-
Third Security, LLC83.5MShares$124 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD17.5MShares$26 Million1.27% of portfolio
-
Black Rock Inc. New York, NY10.4MShares$15.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.03MShares$4.52 Million0.0% of portfolio
-
State Street Corp Boston, MA2.83MShares$4.21 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $310M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...